The company based in Lexington County received its inspection report back from federal regulators. Here’s what it showed.
Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. | Nephron ...
Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback